Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

The integrative management of treatment-resistant depression: a comprehensive review and perspectives.

Carvalho AF, Berk M, Hyphantis TN, McIntyre RS.

Psychother Psychosom. 2014;83(2):70-88. doi: 10.1159/000357500. Epub 2014 Jan 22. Review.

PMID:
24458008
[PubMed - indexed for MEDLINE]
2.

Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.

Edwards SJ, Hamilton V, Nherera L, Trevor N.

Health Technol Assess. 2013 Nov;17(54):1-190. doi: 10.3310/hta17540. Review.

PMID:
24284258
[PubMed - indexed for MEDLINE]
Free Article
3.

If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies.

Connolly KR, Thase ME.

Drugs. 2011 Jan 1;71(1):43-64. doi: 10.2165/11587620-000000000-00000. Review.

PMID:
21175239
[PubMed - indexed for MEDLINE]
4.

Evidence for the benefits of nonantipsychotic pharmacological augmentation in the treatment of depression.

Chang CM, Sato S, Han C.

CNS Drugs. 2013 May;27 Suppl 1:S21-7. doi: 10.1007/s40263-012-0030-1. Review.

PMID:
23712796
[PubMed - indexed for MEDLINE]
5.

Therapeutic options for treatment-resistant depression.

Shelton RC, Osuntokun O, Heinloth AN, Corya SA.

CNS Drugs. 2010 Feb;24(2):131-61. doi: 10.2165/11530280-000000000-00000. Review.

PMID:
20088620
[PubMed - indexed for MEDLINE]
6.

Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach.

McIntyre RS, Filteau MJ, Martin L, Patry S, Carvalho A, Cha DS, Barakat M, Miguelez M.

J Affect Disord. 2014 Mar;156:1-7. doi: 10.1016/j.jad.2013.10.043. Epub 2013 Nov 15. Review.

PMID:
24314926
[PubMed - indexed for MEDLINE]
7.

Augmentation strategies for treatment-resistant depression.

Carvalho AF, Machado JR, Cavalcante JL.

Curr Opin Psychiatry. 2009 Jan;22(1):7-12. doi: 10.1097/YCO.0b013e32831be9ef. Review.

PMID:
19122528
[PubMed - indexed for MEDLINE]
8.

Pharmacological interventions for somatoform disorders in adults.

Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ.

Cochrane Database Syst Rev. 2014 Nov 7;11:CD010628. doi: 10.1002/14651858.CD010628.pub2. Review.

PMID:
25379990
[PubMed - indexed for MEDLINE]
9.

The hidden third: improving outcome in treatment-resistant depression.

Schlaepfer TE, Agren H, Monteleone P, Gasto C, Pitchot W, Rouillon F, Nutt DJ, Kasper S.

J Psychopharmacol. 2012 May;26(5):587-602. doi: 10.1177/0269881111431748. Epub 2012 Jan 11. Review.

PMID:
22236505
[PubMed - indexed for MEDLINE]
10.

Role of lithium augmentation in the management of major depressive disorder.

Bauer M, Adli M, Ricken R, Severus E, Pilhatsch M.

CNS Drugs. 2014 Apr;28(4):331-42. doi: 10.1007/s40263-014-0152-8. Review.

PMID:
24590663
[PubMed - indexed for MEDLINE]
11.

Augmentation strategies for treatment-resistant depression: a literature review.

Carvalho AF, Cavalcante JL, Castelo MS, Lima MC.

J Clin Pharm Ther. 2007 Oct;32(5):415-28. Review.

PMID:
17875106
[PubMed - indexed for MEDLINE]
12.

Using adjunctive treatments when first-line antidepressants fail.

Thase ME.

J Clin Psychiatry. 2012 Jan;73(1):e01. doi: 10.4088/JCP.10126tx4c.

PMID:
22316580
[PubMed - indexed for MEDLINE]
13.

Management of treatment-resistant depression.

Keitner GI, Mansfield AK.

Psychiatr Clin North Am. 2012 Mar;35(1):249-65. doi: 10.1016/j.psc.2011.11.004. Epub 2011 Dec 21. Review.

PMID:
22370501
[PubMed - indexed for MEDLINE]
14.

Augmentation treatments with second-generation antipsychotics to antidepressants in treatment-resistant depression.

Kato M, Chang CM.

CNS Drugs. 2013 May;27 Suppl 1:S11-9. doi: 10.1007/s40263-012-0029-7. Review.

PMID:
23709358
[PubMed - indexed for MEDLINE]
15.

[Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].

Erbe S, Gutwinski S, Bschor T.

Psychiatr Prax. 2012 Mar;39(2):57-63. doi: 10.1055/s-0031-1277013. Epub 2011 Dec 21. Review. German.

PMID:
22189902
[PubMed - indexed for MEDLINE]
16.

Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.

Bobo WV, Shelton RC.

Expert Rev Neurother. 2010 May;10(5):651-70. doi: 10.1586/ern.10.44. Review.

PMID:
20420487
[PubMed - indexed for MEDLINE]
17.

Therapeutic options in treatment-resistant depression.

Vieta E, Colom F.

Ann Med. 2011 Nov;43(7):512-30. doi: 10.3109/07853890.2011.583675. Epub 2011 May 31. Review.

PMID:
21623700
[PubMed - indexed for MEDLINE]
18.
19.

Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol.

Furukawa TA, Akechi T, Shimodera S, Yamada M, Miki K, Watanabe N, Inagaki M, Yonemoto N.

Trials. 2011 May 11;12:116. doi: 10.1186/1745-6215-12-116.

PMID:
21569309
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk